ACADIA PharmaceuticalsvsJohnson & Johnson

ACAD and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

ACAD

ACADIA Pharmaceuticals Inc.

$17.83

Value $3.0B

-2.67%
ACAD's page

ACADIA Pharmaceuticals (ACAD) has a market value of $3.0B and Johnson & Johnson (JNJ) $657B. Over the last year, with dividends, ACAD moved -25.7% and JNJ +39.7%. Dividend yield: ACAD none, JNJ 1.94%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ACAD$3.0B

    JNJ$657B

    JNJ is 216 times ACAD

  • Revenue, 12 months

    ACAD$1.2B

    JNJ$99.3B

    JNJ is 83 times ACAD

  • Net income, 12 months

    ACAD$362M

    JNJ$16.1B

    JNJ is 44 times ACAD

  • Operating margin

    ACAD10.2%

    JNJ–

  • ROIC

    ACAD7.9%

    JNJ12.4%

    4.5 points apart

  • P/E

    ACAD–

    JNJ40.8

  • Dividend yield

    ACAD0.0%

    JNJ1.9%

    1.9 points apart

  • 5-year return

    ACAD-8.5%

    JNJ+92.0%

    100.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ACAD-8.5%

JNJ+92.0%

10015020020222023202420252026
Returns by period
PeriodACADWith dividendsJNJWith dividends
1 year since November 17, 2025-25.7%Price -25.7%+39.7%Price +36.6%
3 years since November 17, 2023-21.9%-7.9% a yearPrice -21.9%+98.2%+25.6% a yearPrice +82.1%
5 years since November 17, 2021-8.5%-1.8% a yearPrice -8.5%+92.0%+13.9% a yearPrice +67.0%
10 years since November 18, 2016-39.6%-4.9% a yearPrice -39.6%+208.0%+11.9% a yearPrice +136.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ACADACADIA PharmaceuticalsJNJJohnson & Johnson

Valuation

ACADJNJ
Valuation
Price$17.83$272.70
Market value$3.0B$657B
Enterprise value (EV)$2.1B$685B
P/E–40.8
P/E, 5-year median–21.9
P/B2.28.1
EV/EBIT16.938.6
Free cash flow yield2.7%3.1%

Results and growth

ACADJNJ
Results and growth
Revenue, 12 months$1.2B$99.3B
Net income, 12 months$362M$16.1B
Free cash flow, 12 months$82M$20.6B
Earnings per share, 12 months$2.12$6.59
Revenue growth, year on year11.9%6.1%
Revenue growth a year, past+19.4%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

ACADJNJ
Margins and returns on capital
Gross margin90.5%67.6%
Operating margin10.2%–
Net margin30.1%16.2%
ROIC7.9%12.4%
ROE29.8%19.7%

Balance sheet

ACADJNJ
Balance sheet
Cash$976M$17.2B
Total debt$72M$44.7B
Net debt / EBITDA-7.91.1
Interest cover–18.0×

Dividends and buybacks

ACADJNJ
Dividends and buybacks
Dividend yield–1.9%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield–0.9%
Shareholder yield–2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ACAD or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, ACADIA Pharmaceuticals or Johnson & Johnson?

By market value, Johnson & Johnson ($657B) is about 216.2 times ACADIA Pharmaceuticals ($3.0B), at today's prices.

How did ACAD and JNJ stock do over the last 10 years?

Since November 18, 2016, ACAD's price moved -39.6% and JNJ's +136.4%. With dividends: ACAD -39.6% (-4.9% a year), JNJ +208.0% (+11.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, ACAD or JNJ?

The dividend yield at today's price is none for ACADIA Pharmaceuticals and 1.94% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

Which has the higher profit margins, ACADIA Pharmaceuticals or Johnson & Johnson?

Over the last twelve months, the net margin was 30.1% for ACADIA Pharmaceuticals and 16.2% for Johnson & Johnson, and the operating margin 10.2% and –. Revenue was $1.2B and $99.3B.

Which is the better investment, ACADIA Pharmaceuticals or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.